Stocktoria

Aurobindo Pharma Limited AUROPHARMA.NS

IN · National Stock Exchange of India · XNSE · stock · Healthcare · website

Aurobindo Pharma Limited statistics & valuation

Market cap₹903.4B
P / E25.8×
P / S2.7×
P / B2.4×
P / FCF37.3×
Dividend yield0.26%
Net margin10.5%
Return on equity9.2%
FCF margin7.3%
Net debt₹8.8B
Enterprise value USD$9.6B
Earnings yield EBIT/EV5.6%
Return on capital12.5%

Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
7.80% 11.10% 11.10% 10.50% 2023202420252026
Gross margin (%)
51.70% 53.90% 58.50% 59.60% 2023202420252026
Operating margin (%)
10.30% 15.50% 15.80% 15.20% 2023202420252026
Return on equity (%)
7.20% 10.60% 10.70% 9.20% 2023202420252026
Shares outstanding
575.4M 575.4M 575.4M 575.4M 2023202420252026
Net debt (₹)
₹8.90B ₹32.54B ₹26.94B ₹8.81B 2023202420252026
Share buybacks (₹)
₹0 ₹9.30B ₹0 2023202420252026
Return on assets (%)
4.80% 7.00% 7.00% 6.00% 2023202420252026
Free cash flow margin (%)
-1.40% -3.90% 4.50% 7.30% 2023202420252026
Debt / equity (×)
0.20× 0.22× 0.25× 0.21× 2023202420252026
EPS (₹)
₹32.90 ₹54.16 ₹59.81 2023202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024FY2023
Gross margin59.6%58.5%53.9%51.7%
Operating margin15.2%15.8%15.5%10.3%
Net margin10.5%11.1%11.1%7.8%
FCF margin7.3%4.5%-3.9%-1.4%
Return on assets6.0%7.0%7.0%4.8%
Return on equity9.2%10.7%10.6%7.2%
Debt / equity0.02×0.05×0.07×0.02×
Current ratio1.811.851.981.87

Computed from company filings · IN · as of 2026-03-31. Figures in INR. Facts plus Stocktoria's own computed scores — not investment advice.